| scholarly article | Q13442814 |
| P50 | author | Taylor-Jade Woods | Q90637787 |
| Fisaha Tesfay | Q93255706 | ||
| P2093 | author name string | Peter Speck | |
| Billingsley Kaambwa | |||
| P2860 | cites work | Rating satisfaction research: is it poor, fair, good, very good, or excellent? | Q74238936 |
| Cost-effectiveness of adjunctive hyperbaric oxygen in the treatment of diabetic ulcers | Q79957257 | ||
| Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures | Q80012455 | ||
| Clinical evidence for and cost-effectiveness of advanced cellular tissue products for the treatment of diabetic foot ulcers | Q90942197 | ||
| Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period | Q91368707 | ||
| Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers | Q91877342 | ||
| Fibreglass Total Contact Casting, Removable Cast Walkers, and Irremovable Cast Walkers to Treat Diabetic Neuropathic Foot Ulcers: A Health Technology Assessment | Q95724974 | ||
| An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds | Q47204222 | ||
| Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes | Q47247481 | ||
| Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting | Q47662086 | ||
| An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers | Q47793526 | ||
| A cost-effectiveness analysis of optimal care for diabetic foot ulcers in Australia | Q48128360 | ||
| Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer. | Q49420123 | ||
| The cost effectiveness of Apligraf treatment of diabetic foot ulcers. | Q51803919 | ||
| Potential cost-effectiveness of using a collagen-containing dressing in managing diabetic foot ulcers in the UK. | Q52672177 | ||
| Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. | Q53291347 | ||
| Foot infections in diabetic patients. Decision and cost-effectiveness analyses. | Q53647051 | ||
| Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial. | Q53987796 | ||
| Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers. | Q55396609 | ||
| A model to analyse costs and benefit of intensified diabetic foot care in Austria | Q57259477 | ||
| Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes | Q59241172 | ||
| Costs of deep foot infections in patients with diabetes mellitus | Q73369638 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 | ||
| The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data | Q31031964 | ||
| Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers. | Q33699377 | ||
| Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcers: A Health Technology Assessment | Q33739565 | ||
| A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments | Q34380668 | ||
| On the decision rules of cost-effective treatment for patients with diabetic foot syndrome | Q35205374 | ||
| The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru | Q35821874 | ||
| Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success | Q36129852 | ||
| The global burden of diabetic foot disease | Q36314091 | ||
| A systematic review of economic evaluations of population-based sodium reduction interventions | Q36326669 | ||
| Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis | Q36359325 | ||
| The clinical and economic potential of hyperbaric oxygen therapy in the treatment of diabetic ulceration and other conditions | Q36957286 | ||
| Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. | Q37133401 | ||
| Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers | Q37239300 | ||
| Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? | Q37328865 | ||
| Cost of treating diabetic foot ulcers in five different countries | Q37978282 | ||
| Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. | Q38093984 | ||
| Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis | Q38284156 | ||
| Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trial | Q38667589 | ||
| WHS guidelines update: Diabetic foot ulcer treatment guidelines | Q38668360 | ||
| Descriptive, Longitudinal Study Results Applied to Statistical Models to Assess the Impact of Early Microbiological Cultures on the Economic Burden of Treatment for Infected Diabetic Foot Ulcers at a Mexican Public Health Facility | Q39038793 | ||
| Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. | Q39040207 | ||
| Cost-Effectiveness of Becaplermin Gel on Diabetic Foot Ulcer HealingChanges in Wound Surface Area | Q39859593 | ||
| Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK. | Q39929915 | ||
| Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes. | Q40270316 | ||
| Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations | Q40674873 | ||
| Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs. | Q40780498 | ||
| The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus | Q40979823 | ||
| Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products | Q41236010 | ||
| Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments | Q43752527 | ||
| Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients | Q44223071 | ||
| Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections | Q44563967 | ||
| An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers | Q46622818 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | e0232395 | |
| P577 | publication date | 2020-04-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: A systematic review | |
| P478 | volume | 15 |
Search more.